Biotricity Inc. Reveals Positive Financial Results for Q2 FY25REDWOOD CITY, Calif. — November 15, 2024 — Biotricity Inc. (OTCMKTS:BTCY) disclosed its financial outcomes for the second quarter of fiscal 2025, ending September 30, 2024. The company sho

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Biotricity’s 8K filing here. About Biotricity (Get Free Report) Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring […]

Leave a Reply

Your email address will not be published.

Previous post Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Overweight at Cantor Fitzgerald
Next post Golub Capital BDC, Inc. (NASDAQ:GBDC) Plans $0.39 Quarterly Dividend